APA

Kaewpongsri S., Sriprawat K., Suwanarusk R., Kyle D. E., Lek-Uthai U., Leimanis M., Lwin K. M., Phyo A. P., Zwang J., Russell B., Nosten F. & Renia L. (20110601). The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum. : Antimicrobial agents and chemotherapy.

Chicago

Kaewpongsri S, Sriprawat K, Suwanarusk R, Kyle D E, Lek-Uthai U, Leimanis M, Lwin K M, Phyo A P, Zwang J, Russell B, Nosten F and Renia L. 20110601. The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum. : Antimicrobial agents and chemotherapy.

Harvard

Kaewpongsri S., Sriprawat K., Suwanarusk R., Kyle D. E., Lek-Uthai U., Leimanis M., Lwin K. M., Phyo A. P., Zwang J., Russell B., Nosten F. and Renia L. (20110601). The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum. : Antimicrobial agents and chemotherapy.

MLA

Kaewpongsri S, Sriprawat K, Suwanarusk R, Kyle D E, Lek-Uthai U, Leimanis M, Lwin K M, Phyo A P, Zwang J, Russell B, Nosten F and Renia L. The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum. : Antimicrobial agents and chemotherapy. 20110601.